This is the original version (as it was originally made).
15. The cases and circumstances prescribed for the purposes of sections 108(7) and 111(7) of the Act in which persons are exempt from the requirements of section 108(1)(a) of the Act (to carry out a risk assessment) and of section 111(1)(a) of the Act (to obtain consent), respectively, insofar as they relate to marketing genetically modified organisms, are all cases and circumstances in which—
(a)an approved product is marketed for a use for which it has approval,
(b)genetically modified micro-organisms are made available for activities regulated under the Contained Use Directive,
(c)genetically modified organisms other than micro-organisms falling within paragraph (b) are made available to be used exclusively for activities where appropriate stringent containment measures based on the same principles of containment as laid down in the Contained Use Directive are used to limit their contact with and to provide a high level of safety for the general population and the environment,
(d)genetically modified organisms are made available to be used exclusively for deliberate releases complying with the requirements laid down in Part II,
(e)a genetically modified organism authorised under Council Regulation (EEC) No. 2309/93(1), as amended by Commission Regulation EC No 649/98(2), is marketed, or
(f)a novel food or novel food ingredient within the scope of Regulation EC No. 258/97 of the European Parliament and of the Council(3) is marketed.
OJ No L214, 24.8.1993, p. 1.
OJ No L88, 24.3.1998, p. 7.
OJ No L43, 14.2.1997, p. 1.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
